ADAGAdagene Inc.

Nasdaq adagene.com


$ 2.93 $ -0.02 (-0.68 %)    

Monday, 26-Aug-2024 11:45:02 EDT
QQQ $ 474.15 $ -5.78 (-1.2 %)
DIA $ 412.83 $ 1.00 (0.24 %)
SPY $ 559.55 $ -3.64 (-0.65 %)
TLT $ 98.23 $ -0.42 (-0.43 %)
GLD $ 232.64 $ -0.84 (-0.36 %)
$ 2.95
$ 2.96
$ 2.95 x 100
-- x --
$ 2.93 - $ 2.96
$ 1.10 - $ 4.38
2,188,677
na
130.14M
$ 0.64
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 adagene-h1-eps-026
Adagene H1 EPS $(0.26)
07/25/2024 20:41:52

Adagene (NASDAQ:ADAG) reported quarterly losses of $(0.26) per share.

 hc-wainwright--co-reiterates-buy-on-adagene-maintains-5-price-target

HC Wainwright & Co. analyst Arthur He reiterates Adagene (NASDAQ:ADAG) with a Buy and maintains $5 price target.

 hc-wainwright--co-reiterates-buy-on-adagene-maintains-5-price-target

HC Wainwright & Co. analyst Arthur He reiterates Adagene (NASDAQ:ADAG) with a Buy and maintains $5 price target.

Core News & Articles

Interim data from additional MSS CRC patients dosed at 10 mg/kg every three weeks (Q3W) in combination with pembrolizumab antic...

 why-transcode-therapeutics-shares-are-trading-lower-by-over-24-here-are-other-stocks-moving-in-fridays-mid-day-session

Shares of TransCode Therapeutics, Inc. (NASDAQ: RNAZ) fell sharply during Friday’s session. TransCode Therapeutics priced a 5,...

 why-airspan-networks-shares-are-trading-higher-by-over-380-here-are-other-stocks-moving-in-wednesdays-mid-day-session

Shares of Airspan Networks Holdings Inc. (NASDAQ: MIMO) shares rose sharply during Wednesday’s session after the company announ...

 why-is-cancer-focused-adagene-stock-plummeting-today

Adagene presents results at ASCO 2024 Gastrointestinal Cancers Symposium. ADG126, combined with Merck's Keytruda, shows lim...

 why-datchat-shares-are-trading-lower-by-around-33-here-are-20-stocks-moving-premarket

Shares of DatChat, Inc. (NASDAQ: DATS) fell sharply in pre-market trading after announcing a proposed underwritten public offe...

 adagene-announces-interim-results-from-masked-anti-ctla-4-safebody-adg126-in-combination-with-pembrolizumab-in-metastatic-microsatellite-stable-colorectal-cancer

- Data from first tranche of MSS CRC patients treated with ADG126 10 mg/kg every three weeks (Q3W) in dose expansion showed cli...

 adagene-presents-data-demonstrating-the-best-in-class-therapeutic-index-for-masked-anti-ctla-4-safebody-adg126-at-sitc-2023

- MSS CRC case examples reinforce optimal dosing regimen in ongoing phase 2 dose expansion, with a confirmed partial response a...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION